Physician profile
John E Otoole
NPI 1619926672
$592,803.79
in general payments reported to CMS, 2019-2025
7 companies · $122K in 2025
The $122K reported for 2025 was more than what 98% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $42K · 2021: $82K · 2022: $81K · 2023: $117K · 2024: $92K · 2025: $122K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $295K · Consulting Fee: $27K · Travel and Lodging: $6,609 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $295,053.92 |
| Consulting Fee | $27,337.50 |
| Travel and Lodging | $6,608.73 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Food and Beverage | $757.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $530,282.66 | 2019-2025 | Hedron, Hedron Ia, Capitol / Retractor |
| Surgalign Spine Technologies, INC. | $40,299.11 | 2019-2020 | |
| Cerapedics INC. | $10,908.64 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Viseon, INC. | $5,250.00 | 2021 | |
| Synthes Gmbh | $4,553.57 | 2024-2025 | |
| Icotec Medical INC. | $1,500.00 | 2025 | |
| Orthofix Medical, INC. | $9.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$114,207.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Otoole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.